title: Don't miss the base - keratoacanthoma-type squamous cell carcinoma with perineural invasion during BRAF inhibitor therapy for melanoma.
authors.affiliation: Department of Dermatology, Venereology, und Allergology, University Medical Center Leipzig, Leipzig, Germany.
authors.forename: Monica
authors.initials: M
authors.lastname: Schüürmann
authors.affiliation: Department of Dermatology, Venereology, und Allergology, University Medical Center Leipzig, Leipzig, Germany.
authors.forename: Iris
authors.initials: I
authors.lastname: Pönitzsch
authors.affiliation: Department of Dermatology, Venereology, und Allergology, University Medical Center Leipzig, Leipzig, Germany.
authors.forename: Jan Christoph
authors.initials: JC
authors.lastname: Simon
authors.affiliation: Department of Dermatology, Venereology, und Allergology, University Medical Center Leipzig, Leipzig, Germany.
authors.forename: Mirjana
authors.initials: M
authors.lastname: Ziemer
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced* / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage* / Q000009:adverse effects; D007636:Keratoacanthoma / Q000139:chemically induced / Q000473:pathology; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D009361:Neoplasm Invasiveness; D010524:Peripheral Nervous System Neoplasms / Q000139:chemically induced* / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors*; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf